Compositions and methods for treating meibomian gland dysfunction
AssigneeCloudbreak Therapeutics, LLC
InventorsJinsong Ni, Rong Yang
Life of this patent
Estimating the term…
Abstract
A method for treating a meibomian gland dysfunction of an affected eye includes administering to the affected eye of a subject in need of such treatment a steroidal-androgen-free composition containing a therapeutically effective amount of a cyclic polysaccharide. A steroidal-androgen-free composition includes a cyclic polysaccharide as an active pharmaceutical ingredient for treating a meibomian gland dysfunction of an affected eye.
Claims12
A method for treating a meibomian gland dysfunction of an affected eye, comprising administering to the affected eye of a subject in need of such treatment a steroidal-androgen-free composition containing a therapeutically effective amount of 2-hydroxypropyl-beta-cyclodextrin,
- wherein the 2-hydroxypropyl-beta-cyclodextrin is an active pharmaceutical ingredient for treating the meibomian gland dysfunction, and
- wherein the 2-hydroxypropyl-beta-cyclodextrin is a sole active pharmaceutical ingredient for treating the meibomian gland dysfunction.
A method for treating a meibomian gland dysfunction of an affected eye, comprising administering to the affected eye of a subject in need of such treatment a steroidal-androgen-free composition consisting essentially of 2-hydroxypropyl-beta-cyclodextrin and one or more ingredients selected from the group consisting of hydroxypropyl guar, xantham gum, trehalose, sodium chloride, castor oil, Polysorbate 80, HPMC 2910, edetate disodium, glycerin, a buffer, and water,
- wherein the 2-hydroxypropyl-beta-cyclodextrin is a sole active pharmaceutical ingredient for treating the meibomian gland dysfunction.
Dependencies are inferred from the claim text.